Flotetuzumab Expanded Access Program
NCT04678466
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
AML
AML, Adult Recurrent
Interventions
BIOLOGICAL:
flotetuzumab
Sponsor
MacroGenics